Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Inactive hair follicle stem cells help prevent skin cancer.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Early hair loss may indicate prostate issues.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

PRFM may help treat hair loss, especially in mild cases.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Hair loss in Clouston's syndrome improved with minoxidil and tretinoin treatment.

AMT may cause hair loss and changing dWAT activity could help treat it.